Comparative distribution of marrow CFU‐e and CFU‐gm progenitors in different anatomic sites in the dog-Reference-Cited by-同舟云学术

Comparative distribution of marrow CFU‐e and CFU‐gm progenitors in different anatomic sites in the dog

Published:1990-01 Issue:3 Volume:8 Page:196-208
ISSN:0737-1454
Container-title:The International Journal of Cell Cloning
language:en
Short-container-title:The International Journal of Cell Cloning

Author:

Deldar A.¹,Stevens C. E.¹,Beineke P. J.¹

Affiliation:

1. Toxicology Division, Lilly Research Laboratories, Eli Lilly and Co., Greenfield, Indiana, USA

Publisher

Wiley

Subject

Cell Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/stem.5530080306

Reference30 articles.

1. Cephalosporin-induced alterations in erythroid (CFU-E) and granulocyte-macrophage (CFU-GM) colony-forming capacity in canine bone marrow

2. Leukokinetic Studies. IX. Experimental Evaluation of a Model of Granulopoiesis*

3. Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs

4. Growth in vitro of donor marrow cultured with recipient lymphocytes predicts the fate of marrow grafts in transfused DLA‐identical dogs;Torok‐Storb BJ;Blood,1979

5. Fractionated total body irradiation and autologous bone marrow transplantation in dogs: hemopoietic recovery after various marrow cell doses;Bodenberger U;Exp Hematol,1980

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refinement and verification of test conditions for colony-forming unit assay in dog bone marrow cells with preservable colony specimens;Comparative Clinical Pathology;2013-05-05

2. Alternative Testing Systems for Evaluating Noncarcinogenic, Hematologic Toxicity;Environmental Health Perspectives;1998-04

3. Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.;Environmental Health Perspectives;1998-04

4. The Use of In Vitro Systems for Evaluating Haematotoxicity;Alternatives to Laboratory Animals;1996-03

5. Development and Application of In Vitro Models of Hematopoiesis to Drug Development;Toxicologic Pathology;1993-03